| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | MEDIVATION INC | 2,198,919 | 283,814,000 | 82.63% | ||
| 2 | AMPIO PHARMACEUTICALS INC | 3,388,322 | 25,514,000 | 7.43% | ||
| 3 | SYNTHETIC BIOLOGICS INC | 3,400,816 | 7,448,000 | 2.17% | ||
| 4 | ALCOBRA LTD | 1,115,315 | 6,279,000 | 1.83% | ||
| 5 | NEWLINK GENETICS CORP | 102,437 | 5,604,000 | 1.63% | ||
| 6 | ADVAXIS INC COM NEW | 275,000 | 3,971,000 | 1.16% | ||
| 7 | KERYX BIOPHARMACEUTICALS INCORPORATED | 200,000 | 2,546,000 | 0.74% | ||
| 8 | BIOBLAST PHARMA LTD | 338,110 | 2,029,000 | 0.59% | ||
| 9 | ALDEYRA THERAPEUTICS INC | 135,800 | 1,382,000 | 0.40% | ||
| 10 | Lion Biotechnologies | 100,000 | 1,211,000 | 0.35% | ||
| 11 | AXIS CAPITAL HOLDING | 112,500 | 1,170,000 | 0.34% | ||
| 12 | PLASMATECH BIOPHARMACEUTICAL | 213,100 | 669,000 | 0.19% | ||
| 13 | Galmed Pharmaceuticals Ltd | 65,000 | 612,000 | 0.18% | ||
| 14 | OHR PHARMACEUTICAL INC | 205,000 | 521,000 | 0.15% | ||
| 15 | Evoke Pharma Inc | 53,839 | 380,000 | 0.11% | ||
| 16 | Zosano Pharma Corp | 20,000 | 202,000 | 0.06% | ||
| 17 | Aptose Biosciences Inc Com New | 20,000 | 108,000 | 0.03% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-15-031597, filed 2015.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
